Ren‐Ching Wang

769 total citations
53 papers, 481 citations indexed

About

Ren‐Ching Wang is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Ren‐Ching Wang has authored 53 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 20 papers in Oncology and 12 papers in Surgery. Recurrent topics in Ren‐Ching Wang's work include Lymphoma Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (14 papers) and Eosinophilic Disorders and Syndromes (5 papers). Ren‐Ching Wang is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (14 papers) and Eosinophilic Disorders and Syndromes (5 papers). Ren‐Ching Wang collaborates with scholars based in Taiwan, United States and Japan. Ren‐Ching Wang's co-authors include Chieh‐Lin Jerry Teng, Shih‐Sung Chuang, Wen‐Li Hwang, Youngsen Yang, Kun‐Chieh Chen, Rong‐San Jiang, Tsung‐Ying Yang, Kuang‐Hsi Chang, Kai‐Li Liang and Gee‐Chen Chang and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Surgical Pathology and Medicine.

In The Last Decade

Ren‐Ching Wang

48 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ren‐Ching Wang Taiwan 12 157 154 141 105 100 53 481
Elizabeth Margolskee United States 13 166 1.1× 174 1.1× 102 0.7× 119 1.1× 73 0.7× 35 494
Chang‐Tsu Yuan Taiwan 13 168 1.1× 137 0.9× 90 0.6× 40 0.4× 55 0.6× 54 424
Xiaohui Zhao United States 12 124 0.8× 105 0.7× 74 0.5× 78 0.7× 69 0.7× 34 432
M. Yadira Hurley United States 15 229 1.5× 144 0.9× 56 0.4× 93 0.9× 86 0.9× 52 651
Ken Gatter United States 16 158 1.0× 94 0.6× 98 0.7× 130 1.2× 48 0.5× 31 498
Mitsutoshi Kurosawa Japan 13 209 1.3× 140 0.9× 108 0.8× 241 2.3× 108 1.1× 49 610
Antonello Podda United States 6 118 0.8× 148 1.0× 117 0.8× 20 0.2× 120 1.2× 12 518
D. Rontogianni Greece 13 138 0.9× 108 0.7× 74 0.5× 51 0.5× 58 0.6× 32 427
Dennis B. Cornfield United States 14 195 1.2× 175 1.1× 58 0.4× 59 0.6× 69 0.7× 29 479
K L Chang United States 7 362 2.3× 302 2.0× 107 0.8× 72 0.7× 86 0.9× 8 620

Countries citing papers authored by Ren‐Ching Wang

Since Specialization
Citations

This map shows the geographic impact of Ren‐Ching Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren‐Ching Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren‐Ching Wang more than expected).

Fields of papers citing papers by Ren‐Ching Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren‐Ching Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren‐Ching Wang. The network helps show where Ren‐Ching Wang may publish in the future.

Co-authorship network of co-authors of Ren‐Ching Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ren‐Ching Wang. A scholar is included among the top collaborators of Ren‐Ching Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren‐Ching Wang. Ren‐Ching Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Chen, Bo‐Jung, Tsung‐Han Hsieh, Chang‐Tsu Yuan, et al.. (2023). Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan. Pathology - Research and Practice. 253. 155059–155059. 2 indexed citations
4.
Wang, Ren‐Ching, et al.. (2022). Investigating early progression of Hodgkin lymphoma in a two-center analysis. Journal of the Formosan Medical Association. 121(7). 1215–1222. 1 indexed citations
5.
Li, Hsin‐Ni, Ren‐Ching Wang, Junpeng Chen, et al.. (2022). Distinctive patterns of marrow involvement by classic Hodgkin lymphoma are clues for diagnosis and subtyping. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(4). 899–907. 1 indexed citations
6.
Wang, Ren‐Ching, et al.. (2022). Clinicopathologic Features of Lymphoproliferative Neoplasms Involving the Liver. Medicina. 58(1). 72–72. 1 indexed citations
7.
Wang, Ren‐Ching, et al.. (2022). Lymph Nodes With Increased IgG4-positive Plasma Cells and Patterns Suspicious for IgG4-related Disease. The American Journal of Surgical Pathology. 47(3). 387–396. 1 indexed citations
8.
Wang, Ren‐Ching, Bo‐Jung Chen, Chang‐Tsu Yuan, et al.. (2022). The spectrum of intestinal mature T- and NK-cell neoplasms in a tertiary center in Taiwan with a high frequency of perforation. Pathology - Research and Practice. 240. 154184–154184. 2 indexed citations
10.
Yu, Wei-Hsiang, Chih‐Hao Li, Ren‐Ching Wang, Chao‐Yuan Yeh, & Shih‐Sung Chuang. (2021). Machine Learning Based on Morphological Features Enables Classification of Primary Intestinal T-Cell Lymphomas. Cancers. 13(21). 5463–5463. 14 indexed citations
11.
Chen, Bo‐Jung, et al.. (2021). Primary cutaneous gamma/delta T‐cell lymphoma in Taiwan: A series of six cases with frequent solitary presentation and relatively indolent behavior. Journal of Cutaneous Pathology. 49(4). 350–357. 1 indexed citations
12.
Wang, Ren‐Ching, et al.. (2020). The cytopathological spectrum of lymphomas in effusions in a tertiary center in Taiwan. Diagnostic Cytopathology. 49(2). 232–240. 4 indexed citations
13.
Li, Hsin‐Ni, Ren‐Ching Wang, Junpeng Chen, Sheng‐Tsung Chang, & Shih‐Sung Chuang. (2020). Density and size of lymphoid follicles are useful clues in differentiating primary intestinal follicular lymphoma from intestinal reactive lymphoid hyperplasia. Diagnostic Pathology. 15(1). 82–82. 4 indexed citations
14.
Wang, Ren‐Ching, Luwei Tao, Akriti Jain, et al.. (2019). Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma. Cureus. 11(4). e4401–e4401. 7 indexed citations
15.
Wang, Ren‐Ching, et al.. (2019). MYD88 L265P mutation analysis is a useful diagnostic adjunct for lymphoplasmacytic lymphoma with pleural effusion. Pathology International. 69(10). 601–607. 4 indexed citations
16.
Takata, Katsuyoshi, et al.. (2017). Primary gastrointestinal anaplastic large cell lymphoma. Pathology. 49(5). 479–485. 8 indexed citations
17.
Tung, C. J., et al.. (2016). A catastrophic cause of bloody stool. Gastrointestinal Endoscopy. 84(2). 381–382.
18.
Weng, Chien‐Hsiang, Ren‐Ching Wang, Cheng-Chung Wu, & Tseng‐Hsi Lin. (2016). Treatment of synchronous adenocarcinoma and lymphoma of the stomach: A case report. Molecular and Clinical Oncology. 5(6). 783–785. 6 indexed citations
19.
Lee, Teng‐Yu, Ren‐Ching Wang, Yi‐Chia Lee, et al.. (2015). The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia. Journal of Clinical Gastroenterology. 50(7). 532–537. 29 indexed citations
20.
Hsu, Shih‐Tien, Ren‐Ching Wang, Chien‐Hsing Lu, et al.. (2013). Report of two cases of adenoid cystic carcinoma of Bartholin's gland and review of literature. Taiwanese Journal of Obstetrics and Gynecology. 52(1). 113–116. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026